Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Relative risk of death from exposure to air pollutants: a short-term (2003-2007) study in Mexicali, Baja California, México.

Reyna MA, Bravo ME, López R, Nieblas EC, Nava ML.

Int J Environ Health Res. 2012;22(4):370-86. doi: 10.1080/09603123.2011.650153. Epub 2012 Mar 15.

PMID:
22420489
2.

Influenza-like illness surveillance on the California-Mexico border, 2004-2009.

Kammerer PE, Montiel S, Kriner P, Bojorquez I, Bejarano Ramirez V, Vazquez-Erlbeck M, Azziz-Baumgartner E, Blair PJ, Hawksworth AW, Faix DJ, Nava ML, Lopez LW, Palacios E, Flores R, Fonseca-Ford M, Phippard A, Lopez K, Johnson J, Bustamante Moreno JG, Russell KL, Waterman SH.

Influenza Other Respir Viruses. 2012 Sep;6(5):358-66. doi: 10.1111/j.1750-2659.2011.00316.x. Epub 2011 Dec 30.

3.

Lipoprotein(a) in plasma, arterial wall, and thrombus from patients with aortic aneurysm.

Papagrigorakis E, Iliopoulos D, Asimacopoulos PJ, Safi HJ, Weilbaecher DJ, Ghazzaly KG, Nava ML, Gaubatz JW, Morrisett JD.

Clin Genet. 1997 Nov;52(5):262-71.

PMID:
9520116
4.

A clinical assessment of the potential for pharmacological interaction between nimesulide and digoxin in patients with heart failure.

Baggio E, Maraffi F, Montalto C, Nava ML, Torti L, Casciarri I.

Drugs. 1993;46 Suppl 1:91-4.

PMID:
7506200
5.

Double-blind evaluation of nimesulide vs lysine-aspirin in the treatment of paediatric acute respiratory tract infections.

Barberi I, Macchia A, Spata N, Scaricabarozzi I, Nava ML.

Drugs. 1993;46 Suppl 1:219-21.

PMID:
7506176
6.

Clinical efficacy and tolerability of nimesulide compared with naproxen in the treatment of posthaemorrhoidectomy pain and inflammation.

Zuckermann M, Panconesi R, Scaricabarozzi I, Nava ML, Bechi P.

Drugs. 1993;46 Suppl 1:177-9.

PMID:
7506165
8.

First dose and steady state pharmacokinetics of nimesulide and its 4-hydroxy metabolite in healthy volunteers.

Gandini R, Montalto C, Castoldi D, Monzani V, Nava ML, Scaricabarozzi I, Vargiu G, Bartosek I.

Farmaco. 1991 Sep;46(9):1071-9.

PMID:
1807292
9.

Polymorphic forms of human apolipoprotein[a]: inheritance and relationship of their molecular weights to plasma levels of lipoprotein[a].

Gaubatz JW, Ghanem KI, Guevara J Jr, Nava ML, Patsch W, Morrisett JD.

J Lipid Res. 1990 Apr;31(4):603-13.

10.

Quantitation and localization of apolipoproteins [a] and B in coronary artery bypass vein grafts resected at re-operation.

Cushing GL, Gaubatz JW, Nava ML, Burdick BJ, Bocan TM, Guyton JR, Weilbaecher D, DeBakey ME, Lawrie GM, Morrisett JD.

Arteriosclerosis. 1989 Sep-Oct;9(5):593-603.

PMID:
2789507
11.

Isolation and characterization of the two major apoproteins in human lipoprotein [a].

Gaubatz JW, Chari MV, Nava ML, Guyton JR, Morrisett JD.

J Lipid Res. 1987 Jan;28(1):69-79.

12.

Effects of chronic tiadenol administration on liver microsomal cytochrome P-450 and associated monooxygenases in the rat.

Maffei Facino R, Carini M, Nava ML, Tofanetti O.

Farmaco Prat. 1983 Dec;38(12):429-38. No abstract available.

PMID:
6662218

Supplemental Content

Loading ...
Support Center